AMC Health

AMC Health is a provider of telehealth and remote patient monitoring solutions that enable healthcare providers, health plans and other organisations to connect with patients outside traditional clinical settings. The company has a long history in virtual care, focusing on patients with chronic conditions such as heart failure, diabetes, hypertension and chronic obstructive pulmonary disease, as well as those recovering after hospital discharge. The problem AMC Health addresses is that many avoidable hospitalisations and complications arise between clinical visits, when changes in a patient’s condition go unnoticed. Its approach is to combine connected medical devices, patient engagement technology and clinical monitoring to identify warning signs early and support timely interventions. By providing a platform that collects physiological data and patient-reported information, AMC Health helps care teams manage larger populations more effectively while giving patients greater confidence in managing their conditions at home.

Key capabilities include remote monitoring kits with cellular or Bluetooth-connected devices such as blood pressure monitors, weight scales, pulse oximeters and glucose meters, together with tablet or mobile applications for symptom surveys, education and video visits. Clinical dashboards present readings and alerts based on configurable thresholds, allowing nurses and clinicians to prioritise outreach. AMC Health can provide clinical monitoring services and logistics support, including device provisioning, shipping and patient onboarding, reducing the operational burden on customers. Integration with electronic health records and care management systems enables data to be shared with the wider care team. Reporting supports programme evaluation, outcomes measurement and reimbursement documentation for remote monitoring services. The platform is designed to meet healthcare privacy and security requirements. Customers typically include health systems, physician practices, accountable care organisations, health plans, pharmaceutical companies conducting clinical research, and government healthcare programmes seeking to reduce readmissions and improve chronic disease management. Pricing starts from around USD 100; there is no free trial and no permanently free version.